These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10856735)

  • 1. Angiotensin converting enzyme (ACE) inhibitors in the treatment of heart failure in general practice in north Cumbria.
    Toal M; Walker R
    Eur J Heart Fail; 2000 Jun; 2(2):201-7. PubMed ID: 10856735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.
    Chin MH; Friedmann PD; Cassel CK; Lang RM
    J Gen Intern Med; 1997 Sep; 12(9):523-30. PubMed ID: 9294785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
    Kasje WN; Denig P; Stewart RE; de Graeff PA; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 2005 Apr; 61(2):145-51. PubMed ID: 15761751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians?
    Davie AP; McMurray JJ
    Postgrad Med J; 1999 Apr; 75(882):219-2. PubMed ID: 10715761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
    Houghton AR; Cowley AJ
    Int J Cardiol; 1997 Mar; 59(1):7-10. PubMed ID: 9080020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure.
    Kalra PA; Kumwenda M; MacDowall P; Roland MO
    BMJ; 1999 Jan; 318(7178):234-7. PubMed ID: 9915733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?
    Kasje WN; Denig P; de Graeff PA; Haaijer-Ruskamp FM
    BMC Fam Pract; 2005 May; 6(1):19. PubMed ID: 15869704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of the dose of ACE inhibitors prescribed by general physicians for patients with heart failure.
    McMullan R; Silke B
    Postgrad Med J; 2001 Dec; 77(914):765-8. PubMed ID: 11723314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacist outreach program directed at physicians treating congestive heart failure.
    Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
    Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition in heart failure: clinical trials and clinical practice.
    Squire lB
    Cardiovasc Drugs Ther; 2002 Jan; 16(1):67-74. PubMed ID: 12085981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underutilisation of ACE inhibitors in patients with congestive heart failure.
    Bungard TJ; McAlister FA; Johnson JA; Tsuyuki RT
    Drugs; 2001; 61(14):2021-33. PubMed ID: 11735631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing heart failure in primary care: first steps in implementing the National Service Framework.
    Gnani S; Gray J; Khunti K; Majeed A
    J Public Health (Oxf); 2004 Mar; 26(1):42-7. PubMed ID: 15044573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to optimum management of heart failure by general practitioners.
    Horne R; Coombes I; Davies G; Hankins M; Vincent R
    Br J Gen Pract; 1999 May; 49(442):353-7. PubMed ID: 10736884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing of ACE inhibitors for cardiovascular disorders in general practice.
    Doyle JC; Mottram DR; Stubbs H
    J Clin Pharm Ther; 1998 Apr; 23(2):133-6. PubMed ID: 9786099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice.
    Rutten FH; Grobbee DE; Hoes AW
    Eur J Heart Fail; 2003 Jun; 5(3):337-44. PubMed ID: 12798832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure.
    Roe CM; Motheral BR; Teitelbaum F; Rich MW
    Am Heart J; 1999 Nov; 138(5 Pt 1):818-25. PubMed ID: 10539811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in family physicians' and cardiologists' care for patients with heart failure.
    Baker DW; Hayes RP; Massie BM; Craig CA
    Am Heart J; 1999 Nov; 138(5 Pt 1):826-34. PubMed ID: 10539812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing and emergency admissions for heart failure in greater Glasgow.
    Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
    J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An audit of echocardiograms in acute left ventricular failure.
    Morgan R; King D
    Postgrad Med J; 1995 Dec; 71(842):738-40. PubMed ID: 8552538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.